Stress News and Research

RSS

Stress hormones may suppress tumor growth: Study

Chronic stress triggers a chain of molecular events that protects breakaway ovarian cancer cells from destruction, a team of researchers led by scientists at The University of Texas M. D. Anderson Cancer Center reports April 12 in the early online publication of the Journal of Clinical Investigation.

13 Apr 2010

Research on efficacy of yoga in breast cancer treatment attracts award of over $4.5M

In an ongoing effort to scientifically validate the age-old belief that mind-body interventions have a beneficial impact on the health of patients, The University of Texas M. D. Anderson Cancer Center has been awarded more than $4.5 million to study the efficacy of incorporating yoga into the treatment program of women with breast cancer.

13 Apr 2010

Lockheed Martin pledges $4M to aid UCLA Health System's Operation Mend program

The Lockheed Martin Corp. announced today a pledge of $4 million to benefit the UCLA Health System's Operation Mend program, which provides reconstructive surgeries and other health care needs to U.S. military personnel wounded in Iraq and Afghanistan.

13 Apr 2010

Stress and genetic factors may raise depression among medical interns

The percentage of clinicians who meet criteria for depression appears to increase significantly during medical internship, according to a report posted online that will appear in the June print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

13 Apr 2010

MIF molecule plays crucial role in neurogenesis

There has been little progress in the way we treat depression and anxiety for over thirty years, but a recent study at EPFL Ecole Polytechnique Fédérale de Lausanne (EPFL) may open the door to new strategies. In an article published online February 23, 2010, in Molecular Psychiatry, researchers from two laboratories at the Brain Mind Institute at EPFL (Ecole Polytechnique Fédérale de Lausanne) explain how understanding the functioning of a molecule called MIF, or macrophage migration inhibitory factor, may change the way we treat depression.

12 Apr 2010

New CZT-based cardiac nuclear imaging system now at Mount Sinai Medical Center

The Mount Sinai Medical Center has become the first in the United States to commercially use a new cardiac nuclear imaging system by GE Healthcare, a cadmium zinc telluride (CZT)-based high-speed, high-resolution camera that drastically reduces imaging time for patients while also reducing radiation exposure compared to previously used technologies.

12 Apr 2010

U-M Medical School researchers earn $366M in NIH research funding in fiscal year 2009

University of Michigan Medical School physicians and scientists earned more than $366 million in National Institutes of Health research funding in federal fiscal year 2009, according to NIH data. In all, the School's faculty brought in more than $435 million in research funding from all sources in U-M fiscal year 2009.

12 Apr 2010

Remediable conditions influence health, development and growth of young children

Pediatric researchers from Boston Medical Center, in partnership with other Children's HealthWatch investigators in Minneapolis, Little Rock, Philadelphia, and Baltimore, have found that the cumulative effects of crowded and unstable housing and uncertain supplies of food and heat act together to decrease the chances of normal growth and development and good physical health among infants and toddlers.

12 Apr 2010

Scientists discover and block pathway responsible for link between stress, anxiety and depression

Scientists at The University of Western Ontario have discovered the biological link between stress, anxiety and depression. By identifying the connecting mechanism in the brain, this high impact research led by Stephen Ferguson of Robarts Research Institute shows exactly how stress and anxiety could lead to depression.

12 Apr 2010

Top state health officials confused over national reform's effects on states

Stateline.org reports on confusion over health care reform at a quarterly meeting with top state health officials in Washington, D.C.: "The session exemplifies the overwhelming sense of confusion among state lawmakers and health care officials around the country as they scramble to figure out what exactly health care reform means for their governments, their citizens and, not least of all, their budgets.

9 Apr 2010

Latest advancement in the development of lab tests for bipolar disorder

Genetic testing may rise to a new level with the findings of Indiana University School of Medicine researchers whose "prototype" for laboratory testing for bipolar disorder appears today in the online edition of the American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.

9 Apr 2010

Tβ4 therapy for ocular disorders closer to reality

RegeneRx Biopharmaceuticals, Inc. announced today that Tβ4, a synthetic version of a naturally occurring peptide that is the basis for the company's product candidates, will be the subject of three poster presentations at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) to be held in Fort Lauderdale, Florida from May 2-6, 2010.

9 Apr 2010

Broken heart disease affects women in post menopause period

It seems an infarction, but it's not. It's called Tako-Tsubo syndrome, or stress-induced cardiomyopathy, and it's a rare disease which at first used to be confused with the far more common (and dangerous) cardiac infarction. Patients arrive to the emergency room with the characteristic heart attack symptoms: acute pain in the chest, an electrocardiogram with the typical changes and the release of those enzymes associated with the usual heart disease.

9 Apr 2010

Increase in delaying retirement likely to gain speed: RAND study

An unprecedented upturn in the number of older Americans who delay retirement is likely to continue and even accelerate over the next two decades, a trend that should help ease the financial challenges facing both Social Security and Medicare, according to a new RAND Corporation study.

9 Apr 2010

Independent management of diabetes a huge issue for teens

It is hard enough being a teenager − or the parent of a teenager − without also having to deal with type 1 diabetes. Keeping good control can be a problem when the responsibility for administering insulin and checking blood glucose levels passes from parent to child.

9 Apr 2010

Omega-3 fatty acids improve nerve regeneration, prevent psychotic disorders and reduce cellular aging

Improving nerve regeneration after corneal surgery, preventing psychotic disorders in those at high risk for them and reducing cellular aging are three emerging benefits of the omega-3 fatty acids found in seafood, according to milestone research described in the April 2010 PUFA Newsletter and Fats of Life online publications for health professionals and consumers, respectively.

9 Apr 2010

Study finds link between autism and social influence

Social influence plays a substantial role in the surging number of autism diagnoses, according to a study published in the American Journal of Sociology.

9 Apr 2010

US Navy submariners banned from smoking

Smoking has now been banned from submarines too says the US Navy. They plan to stock nicotine patches and gums on board to help the sailors quit the habit. This new policy will go into effect before December 31st this year, announced Vice Admiral. John J. Donnelly, commander of the Navy’s submarine forces on Thursday.

9 Apr 2010

Sagent Pharmaceuticals raises $40M through Series B financing

Sagent Pharmaceuticals, a privately held specialty pharmaceutical company, announced today that it has raised $40 million through two tranches of a strategic Series B financing. In this round, a $10 million investment was made by Zhejiang Hisun Pharmaceutical Co. Ltd. (Hisun), and the remaining $30 million was contributed by an unnamed China-focused private equity investment fund. To date, including this financing, Sagent has raised $153 million in equity capital.

9 Apr 2010

University of Southampton, Synairgen Research scientists commence Phase II trial of interferon beta for asthma

Scientists from the University of Southampton and Synairgen Research Ltd, a respiratory drug development company spun out from the University, have begun a Phase II study into the effectiveness of the drug interferon beta for asthma patients.

9 Apr 2010